Product correctly added to cart.

discount label
ASLAN003
View 3D

Biosynth logo

ASLAN003

CAS: 1035688-66-4

Ref. 3D-KRB68866

10mgTo inquire
25mgTo inquire
50mgTo inquire
Estimated delivery in United States, on Tuesday 18 Feb 2025

Product Information

Name:
ASLAN003
Description:

ASLAN003 is a biological product that can be used in the treatment of eye disorders and cancer. ASLAN003 is an antibody that binds to CD20, which is a protein found on the surface of B-cells. When ASLAN003 binds to CD20, it inhibits the growth of B-cells and reduces their viability. This inhibition leads to an increase in the number of myeloid leukemia cells and decreases their diameter, as well as increased phagocytosis by macrophages. The pharmacokinetic properties of ASLAN003 have been studied in humans with solid tumours and myeloid leukemia cell lines. It has been shown that this drug has a long half-life and low clearance rate, allowing for effective pharmacological treatment. Although there are no studies investigating its effects on hematopoietic cells or autoimmune diseases, ASLAN003 has shown potential benefits in these areas as well.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
356.3 g/mol
Formula:
C19H14F2N2O3
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-KRB68866 ASLAN003

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".